A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy (clinicaltrials.gov) - Jun 16, 2025 - P3 | N=216 | Not yet recruiting | Sponsor: Shandong Suncadia Medicine Co., Ltd.
New P3 trial • Cardiomyopathy • Cardiovascular • Hypertrophic Cardiomyopathy • Obstructive Hypertrophic Cardiomyopathy
|